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seems to take place during the 17E embryonic development stage of the
S. lilium. In the caseofA. jamaicensisCGPenteringmeiosis are detected in
stage 17. Therefore, structural changes that lead to ovarian and testicular
development in both species of bats are similar to those observed in
mice, but the differences will be established at the time that these
processes are carried out.
doi:10.1016/j.ydbio.2009.05.112
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The lineage which becomes primordial germ cells (PGCs), and
later the gametes, in various animals is sequestered early during
embryonic development. This population of pluripotent cells is first
observed in the extra-embryonic portion of the mouse epiblast on
day 7.25 of gestation. They then undergo mitosis and migrate,
reaching the genital ridge on day 9.5 of gestation. Marsupial PGCs, by
contrast, are poorly characterized. Meanwhile, the embryos of these
mammals are larger and more accessible because implantation occurs
late during pregnancy, and with only meager yolk-sac adhesivity to
the endometrium. Moreover, the topology of the conceptus and the
superficial position of the fetus itself on the yolk sac suggest that
visualization of PGCs should be amenable to analysis by different
microscopy approaches, including whole-mounts. We are using
immunohistochemistry, fluorescence and confocal microscopy to
determine the expression pattern of the pluripotency cell-marker
proteins encoded by Oct-3/4, vasa, and Nanog. We anticipate our
results to be useful in studying PGC differentiation and migration in
the laboratory opossum. Support for this work was provided by the
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Mammalian oocytes are arrested in meiotic prophase by an
inhibitory signal from the somatic cells of the follicle surrounding
them. Luteinizing hormone (LH) then binds to receptors on the
somatic cells, and causes the oocyte cell cycle to resume, in
preparation for fertilization. We investigated how the somatic cells
regulate the prophase-to-metaphase transition in the oocyte, using
FRET-based cyclic nucleotide sensors in follicle-enclosed mouse
oocytes. Our results show that cGMP passes through gap junctions
from the somatic cells into the oocyte, where it inhibits the hydrolysis
of cAMP by the phosphodiesterase PDE3A. This maintains a high
concentration of cAMP in the oocyte, which inhibits meiotic
progression. LH reverses the inhibition by lowering cGMP in the
somatic cells (from ∼2 μM to ∼80 nM at 1 h after LH) and by closing
gap junctions between the somatic cells. Both of these events cause
oocyte cGMP to decrease (from ∼1 μM to ∼40 nM), which increases
the activity of PDE3A by ∼5-fold. As a result, oocyte cAMP decreases
(from ∼700 nM to ∼140 nM) and meiosis resumes.
doi:10.1016/j.ydbio.2009.05.115
Program/Abstract # 96
The DM domain protein DMRT1 is a dose-sensitive regulator of
germ cell pluripotency
Tony Krentz, Mark Murphy, Vivian Bardwell, David Zarkower
Department of Genetics, Cell Biology and Development, University of
Minnesota, Minneapolis, MN 55455, USA
DMRT1 (Doublesex and Mab 3 Related Transcription factor 1) is a
member of a conserved group of sexual regulators sharing the DM
DNA binding motif. In mice, Dmrt1 is expressed specifically in the
gonad and Dmrt1 null mutants have severe defects in differentiation
of germ and Sertoli cells starting at birth, leading to a highly dysgenic
testis. Dmrt1 mutants on the 129/Sv genetic background develop
testicular germ cell tumors (teratomas) with a very high incidence.
Conditional gene targeting reveals that DMRT1 activity is required
primarily in embryonic germ cells to prevent tumor formation. mRNA
expression profiling at E13.5 comparing 129/Sv wt to Dmrt1 mutants
implicates GDNF signaling as possibly underlying teratoma forma-
tion. GDNF signaling through RET and GFRA1 coreceptors is essential
for survival of undifferentiated spermatocytes in the adult mouse. We
are testing the role of GDNF signaling in 129/Sv embryonic gonads.
129/Sv Dmrt1 mutant gonocytes undergo normal early differentia-
tion, including sex determination, but a subset of germ cells fail to
exit mitosis and ectopically express the pluripotency regulators OCT4,
SOX2 and NANOG. DMRT1 binds to the promoters of cell cycle and
pluripotency regulators in the neonatal testis. Currently we are using
ChIP to test which genes DMRT1 binds in the embryonic testis.
Genetic analysis indicates that Dmrt1 acts as a highly dose sensitive
tumor suppressor gene and that natural variation in DMRT1 activity
can be a factor in germ cell tumor susceptibility. We are investigating
the role of DMRT1 in human germ cell tumors.
doi:10.1016/j.ydbio.2009.05.116
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